Skip to main content
Published locations for FDA approves pembrolizumab for BCG-unresponsive NMIBC with CIS
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA approves pembrolizumab for BCG-unresponsive NMIBC with CIS
User login
Username
Password
Reset your password
/content/fda-approves-pembrolizumab-bcg-unresponsive-nmibc-cis
/oncologypractice/article/215228/genitourinary-cancer/fda-approves-pembrolizumab-bcg-unresponsive
/hematology-oncology/article/215228/genitourinary-cancer/fda-approves-pembrolizumab-bcg-unresponsive